cannabinoid 1 antagonists (Research Triangle Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecannabinoid 1 antagonists (Research Triangle Institute)
Drug Alias NameORG-27569
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesityDiabetes MellitusHepatitis, Alcoholic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRti International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRti International
Active IndicationsN/A
Inactive IndicationsObesityDiabetes MellitusHepatitis, Alcoholic

Other Information

ATC CodeN/A
Related LinksN/A